🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)

RecruitingNAAges 18 Years - 51 YearsFemaleWolfson Medical Center
NCT07158970 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study evaluates the impact of incorporating home-ultrasound (home-US) devices into telemedicine care for patients with gestational diabetes mellitus (GDM). The study will compare satisfaction, clinical outcomes, and healthcare costs between standard high-risk pregnancy care and care augmented by home-US.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Singleton pregnancy * GDM diagnosed by OGTT or glucose monitoring * Hebrew speaking * Compatible cellphone Exclusion Criteria: * Pregestational diabetes * Fetal anomalies/genetic abnormalities * Multifetal pregnancy * Late GDM diagnosis (after 34 weeks)
💊

What it tests

  • Use of the Pulsenmore home ultrasound device for fetal assessment, guided remotely by a physician.
📍

Where

1 site
Edith Wolfson Medical Center
H̱olon, Israel
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy